VEGFA and nonpapillary renal cell carcinoma: Collectively, these results indicated that ccRCC, at least one with CCL2 expression, were sensitive to CCL2 inhibition and that caused additional effects in tumors in addition to antiangiogenesis by VEGF inhibition.